Northern Trust’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Northern Trust’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-202,372	Closed	-$2.49M	–	4672
2022 Q4	$2.49M	Buy	202,372 +35,813	+22%	+$853K	﹤0.01%	2881
2022 Q3	$5.47M	Buy	166,559 +52,617	+46%	+$1.49M	﹤0.01%	2429
2022 Q2	$2.15M	Buy	113,942 +14,345	+14%	+$275K	﹤0.01%	3022
2022 Q1	$1.75M	Buy	+99,597	New	+$2.04M	﹤0.01%	3163

Northern Trust's CINC Position: Q1 2023 in Review

Northern Trust sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 202,372 shares — an estimated $2.49M sold.

Northern Trust first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $5.47M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Northern Trust reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Northern Trust sold 202,372 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $2.49M.
Northern Trust first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Northern Trust's CinCor Pharma, Inc. Common Stock position peaked at $5.47M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.